Featured ArticlesJDD Highlights

View the Latest Discoveries in Aesthetics, Anti-Aging, and Medical Dermatology

By August 31, 2020September 11th, 2020No Comments

Dermatology News

JDD Highlights

September JDD

The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.

Read the September JDD Now

Aesthetics, Public Health, Anti-Aging, and Medical Dermatology

The September issue of the Journal of Drugs in Dermatology is available now. This month, we focus on aesthetic treatments, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.

Article Highlights

 

Editor's Picks

 

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Featured Articles, JDD Re:View, Latest News | No Comments
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Journal of Drugs in Dermatology JDD Article about Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

| Featured Articles, Latest News, Skin of Color | No Comments
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Journal of Drugs in Dermatology JDD Article about Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. Image shows thumb and nail or patient.

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

| Case Reports, Featured Articles, Latest News | No Comments
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…

Leave a Reply